To further our mission, we annually award research grants to institutions and medical professionals whose research focuses on cancers that present the greatest opportunities for a homerun cancer cure.
Note: When clicking the "Submit Grant Application" button below you will be redirected to SnapGrant.com to complete the application process.
The Cure Starts Now has funded $22,574,694 in pediatric brain cancer research in partnership with the DIPG / DMG Collaborative. This includes 139 grants at over 100 hospitals in 17 countries.
Children's National Health System and Children's Research Institute - $125,000
Comprehensive Molecular-Based Cross-Species Comparison of DIPG Biology
Boston Children's Hospital - $110,000
Enabling epigenetic therapies by exploring DIPG chromatin sensitivities
UCL Institute of Child Health - $200,000
T-cell based immunotherapy for DIPG.
Dana Farber Cancer Institute - $100,000
Discovering novel epigenetic dependencies in Diffuse Intrinsic Pontine Glioma
VU University Medical Center - $92,950
Liquid Biopsies for the Monitoring of Diffuse Intrinsic Pontine Glioma.
Children's Cancer Institute - $145,341
Fenretinide, a novel agent targeting RTK/PI3K/AKT network for the treatment of Diffuse Intrinsic Pontine Glioma.
Cincinnati Children's Hospital Medical Center - $200,000
Intra-tumoral heterogeneity in diffuse intrinsic pontine and midline high-grade gliomas
The Hospital for Sick Children - $190,905
Mitochondrial DNA alterations and their potential as a novel therapeutic target in DIPG
Children's National Medical Center - $200,000
Evaluating TORC1/2 kinase inhibition in murine and nonhuman primate (NHP) models
European DIPG Registry - $445,870.12
European DIPG Registry.
Institute of Cancer Research - $99,470
The Evolutionary Dynamics of Diffuse Intrinsic Pontine Glioma.
Stanford University Medical Center - $200,000
Targeting neuronal activity-regulated DIPG infiltration
International DIPG Registry - $699,935
Establishment of an International Diffuse Intrinsic Pontine Glioma (DIPG) Registry
Ann & Robert H. Lurie Children’s Hospital of Chicago - $50,000
Increased Tenascin-C (TNC) protein expression in tumor tissue and CSF in DIPG patients